Report Categories
View AllRecent Articles
View All
Amix Stock Analysis Autonomix Medical Inc. Medtech Stock At 0.4 Gains 3.18 Pct 20260401 1
Old Second OSBC Fell 135 Is a Recovery Ahead 20260515
Tango Therapeutics TNGX Q1 2026 Earnings Miss by Significant Key Takeaways
SES AI Corporation Faces Class Action Lawsuit as Law Firm Alleges Investor Harm
Kellton Tech Slips Over 3 Despite PromoterBacked DII Maintaining Stake at 3297 in Q4FY26
Avidbank AVBH Delivers Q1 2026 Beat EPS 084 vs 082 Expected
OpenAIs Potential IPO Filing Could Mark One of the Largest Public Listings in History
US Treasurys Enter Danger Zone as Surging Yields Stoke Inflation Fears Strategists Warn
Government Plans Major Overhaul of Tax Administration for Smooth GST Rollout
Disney Shares Surge 7 After Streaming and Parks Drive Revenue Beat in First Earnings Report Under CEO Josh DAmaro
CapitaLand Unveils S14 Billion Life Sciences Hub Geneo to Drive Innovation
SpaceX Successfully Launches Starship on Second Attempt Advancing Reusable Rocket Program
The AI Stock That Market Watchers Suggest May Be Undervalued
Nvidia Stock Approaches Critical Technical Level Traders Eye Potential Breakout or Reversal
Federal Reserve Rate Cut Outlook Dims After Strong Jobs Report
CANF Q4 2023 Earnings NarrowerthanExpected Loss Signals Operational Progress
BlackRock Q1 2026 Earnings Strong EPS Beat Driven by Robust Fee Income and Asset Growth
Five Point Holdings Q1 2026 Earnings Narrowing Loss Amid Quiet Quarter
PVL Q1 2023 Earnings Trust Reports EPS of 013 Amid Energy Royalty Trends
ACTU Q1 2026 Earnings EPS Misses Estimates as Biotech Firm Continues RD Investment
CG Oncology Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Continues Investment
Autonomix Medical AMIX Shows Subtle Weakness at 042 as Support and Resistance Tighten
Hyperion DeFi Inc HYPD Faces Selling Pressure as Price Tests Key Support
Aspire Biopharma Holdings Warrants ASBPW Languish at Penny Level as Support and Resistance Converge
NNN REIT Inc NNN Holds Steady Near Support Awaiting Catalyst
Cellebrite CLBT Gains 175 as Support Holds Resistance in Focus
National Research Corporation NRC Slips 053 Tests Key Support Zone